ConductScience.org, home

Paper40990276

Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Chichagi F and 6 others. Curr Cardiol Rev, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Papers, record 40990276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40990276

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
PubMed
Journal
Curr Cardiol Rev
PubMed
Year
2026
PubMed
Publication types
Journal Article, Systematic Review, Meta-Analysis
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-20
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chichagi FFatemeh
2Meftah EElahe
3Rahmati RRahem
4Zarimeidani FFatemeh
5Tavasol AArian
6Mardasi KGKimiya Ghanbari
7Omidi NNegar

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sodium-Glucose Transporter 2 InhibitorsMajor topic
Heart Failure, SystolicMajor topic
Ventricular RemodelingMajor topic
Humans
Randomized Controlled Trials as Topic
Stroke Volume
Ventricular Function, Left

Source PubMed

Download CSV of topics

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124743145Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.J Clin Invest2014https://conductscience.org/library/papers/24743145PubMed
224398230The annual global economic burden of heart failure.Int J Cardiol2014https://conductscience.org/library/papers/24398230PubMed
333129742Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study.JACC Cardiovasc Imaging2021https://conductscience.org/library/papers/33129742PubMed
439544327Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review.J Clin Med Res2024https://conductscience.org/library/papers/39544327PubMed
529203583How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.Diabetes Care2018https://conductscience.org/library/papers/29203583PubMed
638771472The Efficacy and Safety of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors in Real-World Clinical Practice: Potential Cautionary Use in Elderly Patients with Type 2 Diabetes (T2D).Diabetes Ther2024https://conductscience.org/library/papers/38771472PubMed
729603546Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.Diabetes Obes Metab2018https://conductscience.org/library/papers/29603546PubMed
833496189
Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
J Am Heart Assoc2021https://conductscience.org/library/papers/33496189PubMed
921146651Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature.Am Heart J2010https://conductscience.org/library/papers/21146651PubMed
1035902161Expenditure on Heart Failure in the United States: The Medical Expenditure Panel Survey 2009-2018.JACC Heart Fail2022https://conductscience.org/library/papers/35902161PubMed
1133506641Crosstalk between exosomes and autophagy: A review of molecular mechanisms and therapies.J Cell Mol Med2021https://conductscience.org/library/papers/33506641PubMed
1232415802The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study.Diabetes Metab Res Rev2020https://conductscience.org/library/papers/32415802PubMed
1327418546Impact of chronic systolic heart failure on lung structure-function relationships in large airways.Physiol Rep2016https://conductscience.org/library/papers/27418546PubMed
1436308299Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial.Eur Heart J Cardiovasc Pharmacother2023https://conductscience.org/library/papers/36308299PubMed
1538803667SGLT2 inhibition, venous thrombolism, and death due to cardiac causes: a mediation Mendelian randomization study.Front Cardiovasc Med2024https://conductscience.org/library/papers/38803667PubMed
16353634992022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation2022https://conductscience.org/library/papers/35363499PubMed
173594774Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation1987https://conductscience.org/library/papers/3594774PubMed
1839866213Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling.World J Cardiol2025https://conductscience.org/library/papers/39866213PubMed
1936615133Left Ventricular Adverse Remodeling in Ischemic Heart Disease: Emerging Cardiac Magnetic Resonance Imaging Biomarkers.J Clin Med2023https://conductscience.org/library/papers/36615133PubMed
2038644817SGLT-2 inhibitors as novel treatments of multiple organ fibrosis.Heliyon2024https://conductscience.org/library/papers/38644817PubMed

See all 100 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SLC5A26524PubTator's text mininghttps://conductscience.org/library/genes/6524

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40990276

GET https://conductscience.org/api/papers/v1/40990276/references?page=2